CD40 and hepatocellular carcinoma: Fig. 2b, c shows that CD40 protein levels in ACH patients were higher than in HDs or ACs or HCC patients (p < 0.05), and CD40 in Cir patients was higher than in HDs or ACs (p < 0.05).